Janus Henderson Group’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,003,263
Closed -$13.1M 2583
2024
Q1
$13.1M Buy
2,003,263
+578,500
+41% +$3.79M 0.01% 641
2023
Q4
$9.25M Buy
+1,424,763
New +$9.25M 0.01% 686